Assembly Biosciences (ASMB) Cash from Operations (2010 - 2026)

Assembly Biosciences' Cash from Operations history runs 17 years deep, the most recent figure standing at 22097000.0 for Q1 2026.

• In Q1 2026, Cash from Operations rose 5.73% year-over-year to 22097000.0; the TTM figure through Mar 2026 stood at 39751000.0 (up 29.26% YoY), while the FY2025 annual figure was 41093000.0, up 19.61% from the prior year.
• Cash from Operations was 22097000.0 for Q1 2026 at Assembly Biosciences, down from 14237000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 73647000.0 in Q4 2023 to a low of 27502000.0 in Q1 2022.
• Historically, Cash from Operations has averaged 10354529.41 across 5 years, with a median of 17102000.0 in 2024.
• The sharpest annual moves came in 2024 and 2025: Cash from Operations sank 100.55% in 2024, then surged 3598.03% in 2025.
• A 5-year view of Cash from Operations shows it stood at 19254000.0 in 2022, then surged by 482.5% to 73647000.0 in 2023, then plunged by 100.55% to 407000.0 in 2024, then soared by 3598.03% to 14237000.0 in 2025, then slumped by 255.21% to 22097000.0 in 2026.
• The last three Cash from Operations figures came in at 22097000.0 (Q1 2026), 14237000.0 (Q4 2025), and 15133000.0 (Q3 2025), per Business Quant data.